Doe, Simon

The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

Adeloye, D., Elneima, O., Daines, L., Poinasamy, K., Quint, J. K., Walker, S., Brightling, C. E., Siddiqui, S., Hurst, J. R., Chalmers, J. D., et al. (2021) · The Lancet Respiratory Medicine

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 126

Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

Flume, P. A., Biner, R. F., Downey, D. G., Brown, C., Jain, M., Fischer, R., De Boeck, K., Sawicki, G. S., Chang, P., Paz-Diaz, H., et al. (2021) · The Lancet Respiratory Medicine

Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery

Cited by 52

Corrigendum to "Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis" [J Cyst Fibros (2022), 21/2, 323-331]

Bevan, A., Hoo, Z. H., Totton, N., Girling, C., Davids, I. R., Whelan, P., Antrobus, S., Ainsworth, J., Buchan, I., Anderson, A., et al. (2022) · Journal of Cystic Fibrosis

Medication Adherence and ComplianceCystic Fibrosis Research Advances

Cited by 2